Egyptian Association of Vascular Biology and Atherosclerosis (EAVA) consensus on the usage of pro protein convertase subtilisin/kexin type 9 (PCSK9) inhibitors
Ashraf Reda , Ahmed Shawky Elserafy , Elsayed Farag , Tamer Mostafa , Nabil Farag , Atef Elbahry , Osama Sanad , Ahmed Bendary , Ahmed Elkersh , Ihab Attia , Morad Beshay , Mohammed Selim , Hazem Khamis
{"title":"Egyptian Association of Vascular Biology and Atherosclerosis (EAVA) consensus on the usage of pro protein convertase subtilisin/kexin type 9 (PCSK9) inhibitors","authors":"Ashraf Reda , Ahmed Shawky Elserafy , Elsayed Farag , Tamer Mostafa , Nabil Farag , Atef Elbahry , Osama Sanad , Ahmed Bendary , Ahmed Elkersh , Ihab Attia , Morad Beshay , Mohammed Selim , Hazem Khamis","doi":"10.1016/j.atherosclerosissup.2020.01.002","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":8592,"journal":{"name":"Atherosclerosis. Supplements","volume":"41 ","pages":"Page e1"},"PeriodicalIF":0.0000,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.atherosclerosissup.2020.01.002","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Atherosclerosis. Supplements","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1567568820300027","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
期刊介绍：
Atherosclerosis brings together, from all sources, papers concerned with investigation on atherosclerosis, its risk factors and clinical manifestations.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
